Optimal use of aromatase inhibitors for adjuvant treatment of hormone-sensitive early breast cancer: Up front or sequenced after tamoxifen?

被引：0
|
作者：
Cuzick, J.
Sasieni, P.
Howell, A.
机构：
[1] Canc Res UK, London, England
[2] Christie Hosp NHS Trust, Manchester, Lancs, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
541
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinical Utility of Aromatase Inhibitors as Adjuvant Treatment in Postmenopausal Early Breast Cancer
    Loaiza-Bonilla, Arturo
    Socola, Francisco
    Glueck, Stefan
    [J]. CLINICAL MEDICINE INSIGHTS-WOMENS HEALTH, 2013, 6 : 1 - 11
  • [22] Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer
    Buzdar, Aman
    Chlebowski, Rowan
    Cuzick, Jack
    Duffy, Sean
    Forbes, John
    Jonat, Walter
    Ravdin, Peter
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (08) : 1575 - 1585
  • [23] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    [J]. WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [24] Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer
    Ravdin, P
    [J]. LANCET, 2002, 359 (9324): : 2126 - 2127
  • [25] Aromatase Inhibitors for Adjuvant Treatment of Postmenopausal Breast Cancer
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1366): : 47 - 48
  • [26] Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer
    van de Velde, C. J. H.
    Verma, S.
    van Nes, J. G. H.
    Masterman, C.
    Pritchard, K. I.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 (01) : 54 - 62
  • [27] Patterns of care in Dutch postmenopausal patients with hormone-sensitive early breast cancer participating in the Tamoxifen Exemestane Adjuvant Multinational (TEAM) trial
    van Nes, J. G. H.
    Seynaeve, C.
    Maartense, E.
    Roumen, R. M. H.
    de Jong, R. S.
    Beex, L. V. A. M.
    Kranenbarg, W. M. Meershoek-Klein
    Putter, H.
    Nortier, J. W. R.
    van de Velde, C. J. H.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (05) : 974 - 982
  • [28] When to intervene to increase use of adjuvant hormone therapy among women with hormone-sensitive breast cancer
    Quinn, V. P.
    Strauss, J. A.
    Schottinger, J. E.
    Cheetham, C. T.
    Haque, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Comparative economic analysis of aromatase inhibitors and tamoxifen in the treatment of hormone-dependent breast cancer
    Miller, Lesley-Ann N.
    Roy, Anuja
    Mody, Reema
    Higa, Gerald M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1675 - 1691
  • [30] Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancer
    Wenjie Jessie Lu
    Zeruesenay Desta
    David A. Flockhart
    [J]. Breast Cancer Research and Treatment, 2012, 131 : 473 - 481
12345